R52.1 R52.2 F45.41
Conditions
Interventions
Group 1: Patients with chronic pain, which take opioids (WHO II or WHO III) for at least 3 months.
The study is planned as a single-arm observational study. Therefore there are no additional study-a
Sponsors
Charité-Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Written permission for study participation - at least one assured diagnose ICD- 10 R52.1., R52.2 oder F45.41 (chronic pain) - full legal capacity - Good command of the german language - taking WHO II or WHO III opioids for at least 3 months - patients are known by the caregiver for at least one quarter and at least two appointments
Exclusion criteria
Exclusion criteria: None.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reliability and validity of the two questionnaires compared with the external criterion "riskscore". The "riskscore" consists of the following criterions: - Global clinical judgment - alcohol- and tobacco consumption of the patient - Results of the PHQ-4 Questionnaire in terms of fear & depression | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. ROC- analysis will be carried out for both questionnaires individually to determine thresholds. These thresholds will be evaluated , in terms of their abilitly to graduate patients in two categories (high risk, low risk) by AUC- testing. 2. The correlation between the two questionnaires will be evaluated by Pearson correlation coefficient to find out if the thresholds of the two questionnaires classify patients in the same categories (high and low risk). | — |
Countries
Germany
Contacts
Public ContactSascha Tafelski
Charité-Universitätsmedizin Berlin
Outcome results
None listed